Endocrine/Head & Neck and HPB Virtual Poster Grand Rounds

Virtual Moderator(s)

• 

  Miral Grandhi, MD

  Assistant Professor of Surgery
  Rutgers Cancer Institute of New Jersey
  New Brunswick, NJ, United States
• 

  Benzon Dy, MD

  Assistant professor
  Mayo Clinic
  Rochester, MN, United States

Virtual session times are eastern standard time.

Information to participate will be emailed to registrants closer to the date.

non-CME

Presentations:

• 5:00 PM – 5:01 PM CST

  Introductions
• 5:01 PM – 5:04 PM CST

  V31: Assessing the Frequency of Deferrable Thyroid Nodule Biopsies to De-escalate Low-value Care
  

  Virtual Poster Presenter: Sara P. Ginzberg, MD – Hospital of the University of Pennsylvania
• 5:04 PM – 5:07 PM CST

  V32: Baicalein Activates AMPK, Inhibits the Mammalian Target of Rapamycin, and Exhibits Antiproliferative Effects in Pancreatic Neuroendocrine Tumors in vitro and in vivo
  

  Virtual Poster Presenter: Kristen E. Limbach, MD – City of Hope National Medical Center - Duarte, CA
• 5:07 PM – 5:10 PM CST

  V34: The Association Between Patient-reported Symptom Burden and Urgent Healthcare Use in Patients Diagnosed with Neuroendocrine Tumors
  

  Virtual Poster Presenter: Katrina Duncan, MD MPH FRCSC – University of Toronto
• 5:10 PM – 5:13 PM CST

  V33: R0 Resection and Not Larger Surgical Margins Are Associated with Improved Overall Survival in Early Stage Merkel Cell Carcinoma
  

  Virtual Poster Presenter: Sean Nassoiy, DO – Providence Saint John’s Cancer Institute
• 5:13 PM – 5:28 PM CST

  Q&A with Poster Voting
• 5:28 PM – 5:31 PM CST

  V38: Defining Effective Neoadjuvant Chemotherapy (NAC) in PDAC, Implications from Survival and Pattern of Failure in Patients Who Received NAC
  

  Virtual Poster Presenter: Hao Liu, MD PhD – University of Pittsburgh Medical Center
• 5:31 PM – 5:34 PM CST

  V35: All Roads Lead to Rome: Terminal Phenogenotypes of Pancreatic Ductal Adenocarcinoma Do Not Differ Regardless of the Evolutionary Precursor. a Case-control Study
  

  Virtual Poster Presenter: Samer A. Naffouje, MD – Moffitt Cancer Center
• 5:34 PM – 5:37 PM CST

  V48: Risk Assessment and Stratification for Hepatic Resection with Simultaneous Visceral Resection
  

  Virtual Poster Presenter: Andrew J. Sinnamon, MD, MSCE – Moffitt Cancer Institute
• 5:37 PM – 5:40 PM CST

  V37: Circadian Rhythm Gene dec2 Is a Critical Regulator and Potential Therapeutic Target in Pancreatic Cancer Dormancy
  

  Virtual Poster Presenter: Anthony S. Casabianca, MD – University of Rochester
• 5:40 PM – 5:43 PM CST

  V36: Biotissue Training Curriculum Correlates with Intraoperative Performance for Robotic Pancreaticoduodenectomy
  

  Virtual Poster Presenter: Amer H. Zureikat, MD – University of Pittsburgh
• 5:46 PM – 5:49 PM CST

  V46: Postoperative Outcomes and Return to Intended Oncologic Therapy Following Liver Resection in the Geriatric Population
  

  Virtual Poster Presenter: Eric Luo – University of South Florida Morsani College of Medicine
• 5:49 PM – 5:52 PM CST

  V43: Impact of Institutional Adoption of Neoadjuvant Chemotherapy for Stage I Pancreatic Adenocarcinoma on Outcomes
  

  Virtual Poster Presenter: Marco Dal Molin, MD – University of Maryland
• 5:52 PM – 5:55 PM CST

  V44: Location, Location, Location- clinical Trial Location Does Not Influence the Diversity of Pancreatic Cancer Clinical Trials
  

  Virtual Poster Presenter: Kelly M. Herremans, MD – University of Florida
• 5:55 PM – 5:58 PM CST

  V42: galectin-9 Expression and Decreased Survival in Advanced Biliary Tract Cancers
  

  Virtual Poster Presenter: Jessica M. Keilson, MD – Winship Cancer Institute, Emory University
• 5:58 PM – 6:01 PM CST

  V41: Electronic Patient Symptom Reporting System After Hepatopancreatobiliary Surgery
  

  Virtual Poster Presenter: CRISANTA ILAGAN, MD – Memorial Sloan Kettering Cancer Center
• 6:01 PM – 6:04 PM CST

  V50: Using Genome-wide CRISPR Screens to Determine Mechanisms of Drug Resistance in Pancreatic Adenocarcinoma
  

  Virtual Poster Presenter: George A. Alyateem, MD – New York Medical College - Metropolitan Hospital Center
• 6:04 PM – 6:07 PM CST

  V49: Surveillance Patterns and Survival in Hepatocellular Carcinoma: A Seer-medicare Analysis
  

  Virtual Poster Presenter: Marianna V. Papageorge, MD – Boston Medical Center
• 6:07 PM – 6:10 PM CST

  V39: Differentially Expressed Micrornas from Cancer-associated Fibroblasts Display Tumor-suppressive Behaviors in Pancreatic Cancer
  

  Virtual Poster Presenter: Gerik W. Tushoski-Alemán, B.S. B.M. – University of Florida
• 6:10 PM – 6:13 PM CST

  V40: Effect of Hospital Safety Net Designation on Treatment Utilization and Associated Survival in Hepatocellular Carcinoma
  

  Virtual Poster Presenter: Gloria Y. Chang, MD – UTSW
• 6:13 PM – 6:16 PM CST

  V45: Neoadjuvant Therapy in Extrahepatic Cholangiocarcinoma: Improved Outcomes or Just Rearranging the Deck Chairs?
  

  Virtual Poster Presenter: Casey Silver, MD – Northwestern University
• 6:16 PM – 6:19 PM CST

  V47: Predictors of Recurrence and Survival in Resectable Distal Pancreatic Cancer
  

  Virtual Poster Presenter: Amer H. Zureikat, MD – University of Pittsburgh
• 6:19 PM – 6:30 PM CST

  Q&A with Poster Contest Voting